Literature DB >> 12618513

Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?

Aernout Luttun1, Peter Carmeliet.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12618513      PMCID： PMC151908          DOI： 10.1172/JCI18015

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

Review 1.  Pathogenesis and genetics of pre-eclampsia.

Authors:  J M Roberts; D W Cooper
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

Review 2.  Regulation of trophoblast invasion: from normal implantation to pre-eclampsia.

Authors:  Debra Goldman-Wohl; Simcha Yagel
Journal:  Mol Cell Endocrinol       Date:  2002-02-22       Impact factor: 4.102

3.  Ultrastructural differentiation of stromal and vascular components in early macaque placental villi.

Authors:  B F King
Journal:  Am J Anat       Date:  1987-01

4.  Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice.

Authors:  Virginie Mattot; Lieve Moons; Florea Lupu; Daniel Chernavvsky; R Ariel Gómez; Désiré Collen; Peter Carmeliet
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

Review 5.  Animal models of preeclampsia.

Authors:  E Podjarny; C Baylis; G Losonczy
Journal:  Semin Perinatol       Date:  1999-02       Impact factor: 3.300

6.  Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.

Authors:  Yan Zhou; Michael McMaster; Kirstin Woo; Mary Janatpour; Jean Perry; Terhi Karpanen; Kari Alitalo; Caroline Damsky; Susan J Fisher
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

7.  Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

Authors:  Vera Eremina; Manish Sood; Jody Haigh; András Nagy; Ginette Lajoie; Napoleone Ferrara; Hans-Peter Gerber; Yamato Kikkawa; Jeffrey H Miner; Susan E Quaggin
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 9.  Preeclampsia. Part 1: clinical and pathophysiologic considerations.

Authors:  Gabriella Pridjian; Jules B Puschett
Journal:  Obstet Gynecol Surv       Date:  2002-09       Impact factor: 2.347
  9 in total
  28 in total

1.  Interleukin-17 signaling mediates cytolytic natural killer cell activation in response to placental ischemia.

Authors:  Olivia K Travis; Dakota White; Cedar Baik; Chelsea Giachelli; Willie Thompson; Cassandra Stubbs; Mallory Greer; James P Lemon; Jan Michael Williams; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-22       Impact factor: 3.619

2.  Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia.

Authors:  Jen-Ruey Tang; S Ananth Karumanchi; Gregory Seedorf; Neil Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

3.  Pazopanib for renal cell carcinoma leads to elevated mean arterial pressures in a murine model.

Authors:  Amber Kempton; Cody Justice; Aaron Guo; Matthew Cefalu; Michael Makara; Paul Janssen; Thai H Ho; Sakima A Smith
Journal:  Clin Exp Hypertens       Date:  2017-11-27       Impact factor: 1.749

4.  Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

Authors:  Eleazar Soto; Roberto Romero; Juan Pedro Kusanovic; Giovanna Ogge; Youssef Hussein; Lami Yeo; Sonia S Hassan; Chong Jai Kim; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-25

5.  Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis.

Authors:  Deepti Malhotra; Elodie Portales-Casamar; Anju Singh; Siddhartha Srivastava; David Arenillas; Christine Happel; Casper Shyr; Nobunao Wakabayashi; Thomas W Kensler; Wyeth W Wasserman; Shyam Biswal
Journal:  Nucleic Acids Res       Date:  2010-05-11       Impact factor: 16.971

6.  A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

7.  Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Christopher D Kontos; Brian H Annex; Aleksander S Popel
Journal:  Physiol Genomics       Date:  2009-04-07       Impact factor: 3.107

8.  Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Juan Pedro Kusanovic; Eleazar Soto; Jennifer Lam; Zhong Dong; Nandor G Than; Lami Yeo; Edgar Hernandez-Andrade; Agustín Conde-Agudelo; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

Review 9.  Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy.

Authors:  R Simó; C Hernández
Journal:  Diabetologia       Date:  2008-04-11       Impact factor: 10.122

10.  The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.

Authors:  Tinnakorn Chaiworapongsa; Jimmy Espinoza; Francesca Gotsch; Yeon Mee Kim; Gi Jin Kim; Luis F Goncalves; Samuel Edwin; Juan Pedro Kusanovic; Offer Erez; Nandor Gabor Than; Sonia S Hassan; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.